Jeenarine Narine

Jeenarine Narine appears in our data through filings on Elite Pharmaceuticals Inc shares, published by SEC (Form 4). The record holds 62 filings, for trades running from 3 February 2011 to 13 April 2016.

On the open market, the record shows 1 purchase worth €12k and 31 sales worth €2.3M. On balance, insiders were net sellers of €2.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants and 1 option exercise.

The newest entry dates from 15 April 2016: a transaction of €222k, in Elite Pharmaceuticals Inc. The clock since the last published purchase (16 March 2011) now reads 5,716 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.